Clinical Trial for Evaluation of Treatment With Multiple Infusions of Mononuclear Bone Marrow Cells in Patients With Chronic Liver Diseases
NCT02171949 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2017-11-28
Summary
The purpose of this study is to evaluate the safety and efficacy of multiple infusions of mononuclear bone marrow cells in patients with chronic liver diseases.
Conditions
- Chronic Hepatitis
- Hepatic Cirrhosis
Interventions
- BIOLOGICAL
-
Infusion of bone marrow mononuclear cells.
Patients on this group will receive therapy with mononuclear cells. The cells will be diluted on saline and then injected on the hepatic artery through femoral artery puncture.
Sponsors & Collaborators
-
Ministry of Science and Technology, Brazil
collaborator OTHER -
Ministry of Health, Brazil
collaborator OTHER_GOV -
Hospital Sao Rafael
lead OTHER
Principal Investigators
-
André C Lyra, PhD · Hospital São Rafael
-
Bruno SF Souza, MD, Msc · Hospital São Rafael
-
Eduardo L Braga, PhD · Hospital São Rafael
-
Lourianne N Cavalcante, PhD · Hospital São Rafael
-
Milena BP Soares, PhD · Hospital São Rafael
-
Ricardo R dos Santos, PhD · Hospital São Rafael
-
Ticiana F Larocca, MD, Msc · Hospital São Rafael
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-04-30
- Primary Completion
- 2018-12-31
- Completion
- 2019-06-30
Countries
- Brazil
Study Locations
More Related Trials
-
Autologous Bone Marrow Stem Cells in Cirrhosis Patients
NCT00713934 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Intracoronary Infusion of Bone Marrow Mononuclear Cells in Patients With Previous Myocardial Infarction.
NCT01454323 ·Status: COMPLETED ·Phase: PHASE2
-
Autologous Bone Marrow Stem Cell Transplantation in Patients With Subacute Spinal Cord Injury
NCT05671796 ·Status: UNKNOWN ·Phase: PHASE2
-
Autologous Bone Marrow Stem Cells Infusion for the Treatment of Liver Diseases.
NCT02943707 ·Status: UNKNOWN ·Phase: PHASE2
-
Autologous Bone Marrow Mononuclear Cell Implantation for Moderate to Severe Peripheral Arterial Disease
NCT00919516 ·Status: COMPLETED ·Phase: NA
-
Autologous Bone Marrow Stem Cells for Chronic Leg Ulcer Treatment in Sickle Cell Disease
NCT02619734 ·Status: UNKNOWN ·Phase: PHASE1
-
A Phase I/II Safety and Tolerability Dose Escalation Study of Autologous Stem Cells to Patients With Liver Insufficiency
NCT00655707 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Efficacy of Umbilical Cord Blood-Derived Mesenchymal Stem Cells in the Treatment of Long-Term Cytopenia After CAR-T Therapy
NCT07212335 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Cell Therapy in Myocardial Infarction
NCT00350766 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Autologous Bone Marrow Stem Cell Transplantation for Osteonecrosis in Sickle Cell Disease
NCT02448121 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Mesenchymal Stem Cells in the Treatment of Relapsed/Refractory Severe Acquired Aplastic Anemia
NCT01297972 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Long Term Follow-up of Autologous Bone Marrow Mononuclear Cells Therapy in STEMI
NCT00626145 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
IMMNC-HF: IntraMyocardial Injection of Bone Marrow MonoNuclear Cells in Heart Failure (HF) Patients
NCT03227198 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Intracoronary Infusion of Mononuclear Cells Autologous Bone Marrow in Patients With Chronic Coronary Occlusion and Ventricular Dysfunction, Previously Revascularized.
NCT02022514 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Bone Marrow Transfer to Enhance ST-Elevation Infarct Regeneration
NCT00224536 ·Status: COMPLETED ·Phase: PHASE1
-
Compare the Effects of Single Versus Repeated Intracoronary Application of Autologous Bone Marrow-derived Mononuclear Cells on Mortality in Patients With Chronic Post-infarction Heart Failure
NCT01693042 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Hepatic Artery Infusion of CD34+ Cells
NCT00062543 ·Status: WITHDRAWN ·Phase: PHASE1
-
Safety and Efficacy of Human Mesenchymal Stem Cells for Treatment of Liver Failure
NCT01218464 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Autologous Bone Marrow Mononuclear Cells in the Combined Treatment of Coronary Heart Disease
NCT02059512 ·Status: COMPLETED ·Phase: NA
-
ICMNC-HF. IntraCoronary Bone Marrow MonoNuclear Cells in Heart Failure (HF) Patients
NCT03145402 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Study of Human Umbilical Cord Blood (REGENECYTE) Infusion in Patients With Post-COVID Condition
NCT07184385 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Bone Marrow Mesenchymal Stem Cells Transfer in Patients With ST-segment Elevation Myocardial Infarction
NCT04421274 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effectiveness and Safety of Mesenchymal Stem Cell Therapy in Long COVID Patients
NCT06492798 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Autologous Bone Marrow Mononuclear Cell Transplantation for Stroke Patients
NCT01028794 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Cell Therapy in Patients With Chronic Ischemic Heart Disease Undergoing Cardiac Surgery
NCT01267331 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2